The trajectory of the erectile dysfunction drug presents a complex picture for those considering investment. While the initial introduction generated significant gains, the expiration of its exclusive rights opened the https://haimazwbb101125.post-blogs.com/62692040/the-copyright-and-big-pharma-a-risky-investment